Clinical Trial Update: A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating Sensoril for generalized anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Sensoril (Withania somnifera extract)

Snippet

Sponsor: Natreon, Inc. | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: COMPLETED